324 related articles for article (PubMed ID: 36982460)
1. MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection-Narrative Review.
Poniewierska-Baran A; Zadroga Ł; Danilyan E; Małkowska P; Niedźwiedzka-Rystwej P; Pawlik A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982460
[TBL] [Abstract][Full Text] [Related]
2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
[TBL] [Abstract][Full Text] [Related]
4. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
Leibowitz-Amit R; Sidi Y; Avni D
Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma.
Carpi S; Polini B; Fogli S; Podestà A; Ylösmäki E; Cerullo V; Romanini A; Nieri P
Expert Rev Mol Diagn; 2020 Jan; 20(1):19-30. PubMed ID: 31747311
[No Abstract] [Full Text] [Related]
6. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
[No Abstract] [Full Text] [Related]
7. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
Durante G; Broseghini E; Comito F; Naddeo M; Milani M; Salamon I; Campione E; Dika E; Ferracin M
Expert Rev Mol Diagn; 2022 Mar; 22(3):305-318. PubMed ID: 35235479
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers in skin cancer.
Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
11. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
13. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
[TBL] [Abstract][Full Text] [Related]
14. The role of melanocortin 1 receptor in cutaneous malignant melanoma: along the mitogen-activated protein kinase pathway.
Steck MB
Biol Res Nurs; 2014 Oct; 16(4):421-8. PubMed ID: 24443365
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.
Huang SK; Hoon DS
Mol Oncol; 2016 Mar; 10(3):450-63. PubMed ID: 26778792
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma: Underlying epigenetic mechanisms.
Sabit H; Kaliyadan F; Menezes RG
Indian J Dermatol Venereol Leprol; 2020; 86(5):475-481. PubMed ID: 32769310
[TBL] [Abstract][Full Text] [Related]
18. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma.
Jiang L; Lv X; Li J; Li J; Li X; Li W; Li Y
Acta Histochem; 2012 Oct; 114(6):582-8. PubMed ID: 22130252
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating FOXP1.
Sun HW; Yang GL; Wang SN; Zhang YJ; Ding JX; Zhang XN
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8991-8999. PubMed ID: 31696487
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment.
Ak I; Stokkel MP; Bergman W; Pauwels EK
Eur J Nucl Med; 2000 Apr; 27(4):447-58. PubMed ID: 10805119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]